| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly is at the forefront of innovation in product and service development, particularly within the obesity treatment and cancer care markets. The company's promising pipeline of products, including Mounjaro and Zepbound, has generated optimism about revenue growth and market expansion. Recent advancements in healthcare AI and biotechnology further bolster its research and development efforts, ensuring a competitive edge. However, challenges remain as the company navigates clinical trial outcomes and regulatory hurdles. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 1 is bullish. The market sentiment at 2.4 is extremely bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.LLY is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 2.4, and the negative at 0 on 2025-11-25. The forces of Valuation Sentiment (6.6), Sentiment towards Fundamentals (5.2), Market Risk Appetite (1), Sector Price Trend (1), Stock Price Trend (1), Option Sentiment (0), and Price Level Sentiment (0) will drive up the price. The forces of and Price Level Sentiment (0) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-25 | 0%(0.4%) | 1 | 0.25% | 2.4 | 5.2 | 7.5 | |||||||
| 2025-11-24 | 0%(0.4%) | 1 | 0.25% | 2.2 | 5.1 | -1 | |||||||
| 2025-11-23 | 0%(0.4%) | 1 | 0.25% | 2 | 4.7 | -1 | |||||||
| 2025-11-22 | 1%(0.4%) | 1 | 0.25% | 2.1 | 4.7 | 7.5 | |||||||
| 2025-11-21 | 2%(0.3%) | 1 | 0.25% | 2.2 | 4.2 | 7.3 | |||||||
| 2025-11-20 | 0%(0%) | 1 | 0.25% | 1.2 | 3.8 | -1 | |||||||
| 2025-11-19 | 0%(0%) | 1 | 0.25% | 1.1 | 3.5 | 7 | |||||||
| 2025-11-18 | 0%(0%) | 1 | 0.25% | 0.9 | 2.4 | -1 | |||||||
| 2025-11-17 | 0%(0%) | 1 | 0.25% | 1.5 | 2.7 | 7 | |||||||
| 2025-11-16 | 0%(0%) | 1 | 0.25% | 1.6 | 3.1 | 4 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-11-25 17:50:57 The growth in Eli Lilly's stock has significantly increased the assets of the Lilly Endowment. |
| 2025-11-25 17:50:57 Eli Lilly has become the first pharmaceutical company to reach a $1 trillion valuation. |
| 2025-11-25 17:50:57 Eli Lilly's stock has surged to new highs, indicating strong performance in the market. |
| 2025-11-25 17:02:14 The presentation of updated clinical trial results demonstrates Lilly's commitment to innovative research in oncology. |
| 2025-11-25 17:02:14 Changes in investment stakes by asset management firms indicate strategic financial maneuvers related to Eli Lilly. |
| 2025-11-25 17:02:14 Eli Lilly reaching a market capitalization of $1 trillion signifies a major achievement in the pharmaceutical industry. |
| 2025-11-25 17:02:14 The positive movement in Eli Lilly's stock price indicates strong investor confidence and favorable market conditions. |
| 2025-11-25 17:02:14 Eli Lilly's ongoing efforts and presentations related to hormone receptor-positive breast cancer treatments highlight significant advancements in cancer care. |
| 2025-11-25 11:49:35 The strong performance of Eli Lilly's stock indicates investor confidence and potential growth in the pharmaceutical sector. |
| 2025-11-25 11:49:35 Eli Lilly has significantly impacted the pharmaceutical industry and healthcare market, achieving a market cap of $1 trillion. |